Symbicort Turbuhaler

DRUG8 trials

Sponsors

AstraZeneca, Orion Corporation, Orion Pharma, Air Force Military Medical University, China, GlaxoSmithKline

Conditions

AsthmaBronchial AsthmaChronic Obstructive Pulmonary Disease (COPD)Pulmonary Disease, Chronic Obstructive

Phase 1

Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Forte

CompletedNCT01627158

Orion Corporation, Orion PharmaAsthma

Start: 2012-06-30End: 2012-10-31Updated: 2012-10-15

Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler

CompletedNCT03073057

Orion Corporation, Orion PharmaAsthma

Start: 2016-01-31End: 2016-03-31Updated: 2017-03-08

Phase 2

Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease Patients

Air Force Military Medical University, ChinaChronic Obstructive Pulmonary Disease (COPD)

Start: 2013-12-31Target: 40Updated: 2014-03-20

Phase 3

Symbicort Rapihaler Therapeutic Equivalence Study

CompletedNCT00536731

AstraZenecaBronchial Asthma

Start: 2007-09-30End: 2008-04-30Updated: 2012-08-15

Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients

CompletedNCT00837967

AstraZenecaAsthma

Start: 2009-01-31End: 2009-07-31Updated: 2012-08-29

Study to Investigate the Efficacy of Symbicort® SMART.

CompletedNCT00839800

AstraZenecaAsthma

Start: 2009-02-28End: 2011-02-28Updated: 2012-11-30

Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.

CompletedNCT04078126

AstraZenecaChronic Obstructive Pulmonary Disease (COPD)

Start: 2019-09-10End: 2020-12-30Updated: 2022-03-18

Unknown Phase

Comparative Study of Error Rates Between ELLIPTA® Dry Powder Inhaler (DPI) and Other DPIs

CompletedNCT03114969

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2017-06-08End: 2018-03-09Updated: 2020-10-28

Related Papers

Effect of inhaled budesonide/formoterol fumarate dihydrate delivered via two different devices on lung function in patients with COPD and low peak inspiratory flow

Therapeutic Advances in Respiratory Disease2022-01-018 citations

Detecting asthma exacerbations using daily home monitoring and machine learning.

2020-08-1418 citations

Budesonide/formoterol maintenance and reliever therapy via Turbuhaler versus fixed-dose budesonide/formoterol plus terbutaline in patients with asthma: phase III study results.

2013-02-0130 citations

Safety and tolerability of high-dose budesonide/formoterol via Turbuhaler® in Japanese patients with asthma: a randomized, double-blind, crossover, active comparator-controlled, phase III study.

2012-01-012 citations